Imperial College London

Dr. David James PINATO

Faculty of MedicineDepartment of Surgery & Cancer

Clinical Reader in Medical Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2799david.pinato Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Wu:2022:10.1200/JCO.2022.40.4_suppl.399,
author = {Wu, L and Ozbek, U and van, Hyfte G and Reincke, M and Gampa, A and Abugabal, YI and Nishida, N and Wietharn, B and Amara, S and Balcar, L and Pinter, M and Vogel, A and Weinmann, A and Saeed, A and Rimassa, L and Naqash, AR and Muzaffar, M and Huang, Y-H and Pinato, DJ and Ang, C},
doi = {10.1200/JCO.2022.40.4_suppl.399},
publisher = {LIPPINCOTT WILLIAMS & WILKINS},
title = {Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs)},
url = {http://dx.doi.org/10.1200/JCO.2022.40.4_suppl.399},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Wu,L
AU - Ozbek,U
AU - van,Hyfte G
AU - Reincke,M
AU - Gampa,A
AU - Abugabal,YI
AU - Nishida,N
AU - Wietharn,B
AU - Amara,S
AU - Balcar,L
AU - Pinter,M
AU - Vogel,A
AU - Weinmann,A
AU - Saeed,A
AU - Rimassa,L
AU - Naqash,AR
AU - Muzaffar,M
AU - Huang,Y-H
AU - Pinato,DJ
AU - Ang,C
DO - 10.1200/JCO.2022.40.4_suppl.399
PB - LIPPINCOTT WILLIAMS & WILKINS
PY - 2022///
SN - 0732-183X
TI - Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs)
UR - http://dx.doi.org/10.1200/JCO.2022.40.4_suppl.399
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000770995900385&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -